Related references
Note: Only part of the references are listed.EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
Stefano Fanti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Christos Sachpekidis et al.
CLINICAL NUCLEAR MEDICINE (2016)
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging
Emre Demirci et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Isabel Rauscher et al.
CANCER IMAGING (2016)
Prostate Cancer Imaging with Novel PET Tracers
Liza Lindenberg et al.
CURRENT UROLOGY REPORTS (2016)
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer
Laura Evangelista et al.
ABDOMINAL IMAGING (2015)
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
Levent Kabasakal et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with 18F-fluorocholine positron emission tomography/computed tomography
Giuseppe Simone et al.
WORLD JOURNAL OF UROLOGY (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil
Kazuhiro Kitajima et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
Matthias Eder et al.
PHARMACEUTICALS (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Simplified NaCl Based 68Ga Concentration and Labeling Procedure for Rapid Synthesis of 68Ga Radiopharmaceuticals in High Radiochemical Purity
Dirk Mueller et al.
BIOCONJUGATE CHEMISTRY (2012)
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer
Andrea Alfarone et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Prostate cancer: 1HMRS-DCEMR at 3 T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)
Valeria Panebianco et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary
Jeffrey K. Mullins et al.
JOURNAL OF UROLOGY (2012)
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for Ga-68-PET imaging of prostate cancer
Martin Schaefer et al.
EJNMMI RESEARCH (2012)
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
Maria Picchio et al.
EUROPEAN UROLOGY (2011)
Role of MRI in Follow-Up After Focal Therapy for Prostate Carcinoma
Pieter J. De Visschere et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging
Stefano Cirillo et al.
EUROPEAN RADIOLOGY (2009)
New Agents and Techniques for Imaging Prostate Cancer
Atif Zaheer et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
PET Imaging of Prostate Cancer Using Radiolabeled Choline
Mohsen Beheshti et al.
PET CLINICS (2009)
Diagnosis of local recurrence after radical prostatectomy
V Scattoni et al.
BJU INTERNATIONAL (2004)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Multiple vesico-urethral biopsies following radical prostatectomy: The predictive roles of TRUS, DRE, PSA and the pathological stage
V Scattoni et al.
EUROPEAN UROLOGY (2003)
Share Paper
